552 related articles for article (PubMed ID: 6604604)
1. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
2. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; van Es LA
Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610
[TBL] [Abstract][Full Text] [Related]
4. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
Daha MR; van Es LA
J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579
[TBL] [Abstract][Full Text] [Related]
5. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
6. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
Adu D; Williams DG
Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
[TBL] [Abstract][Full Text] [Related]
7. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
9. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
Welch TR; Forristal J; Beischel L
J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
12. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
15. The modulation of immune complex aggregation by classical pathway-mediated reactions.
Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
[TBL] [Abstract][Full Text] [Related]
16. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA; Cats A
Immunology; 1980 Jul; 40(3):417-24. PubMed ID: 6903557
[TBL] [Abstract][Full Text] [Related]
18. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
20. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]